Over-the-counter drug · ANDA
Docosanol NDC 73581-004
Docosanol 100 mg/g · Cream · Topical · YYBA Corp
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73581-004-02 | 73581000402 | 2 TUBE in 1 PACKAGE (73581-004-02) / 2 g in 1 TUBEMarketed from Mar 26, 2025 | |
| 73581-004-03 | 73581000403 | 1 TUBE in 1 PACKAGE (73581-004-03) / 2 g in 1 TUBEMarketed from Mar 26, 2025 | |
| 73581-004-10 | 73581000410 | 1 TUBE in 1 CARTON (73581-004-10) / 1 g in 1 TUBEMarketed from Mar 26, 2025 | |
| 73581-004-20 | 73581000420 | 2 TUBE in 1 CARTON (73581-004-20) / 2 g in 1 TUBEMarketed from Mar 26, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Docosanol
- Generic name (nonproprietary)
- docosanol
- Active ingredients
- Docosanol — 100 mg/g
- Dosage form
- Cream
- Route
- Topical
- Labeler
- YYBA Corp
- Product type
- Over-the-counter drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214454
- Marketing start
- Listing expires
- Identifiers
- Product ID 73581-004_57118a58-dfdd-6764-e063-6394a90aebb6SPL ID 57118a58-dfdd-6764-e063-6394a90aebb6SPL set ID 289e5003-7d08-c141-e063-6394a90abca3RxCUI 797534UNII 9G1OE216XY
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N473581000402followed by a unit qualifier and the quantityPackage 73581-0004-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Uses treats cold sores/fever blisters on the face or lips shortens healing time and duration of symptoms: tingling, pain, burning, and/or itching
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 214454
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.